| Ticker Details |
|
Cogent Biosciences, Inc.
|
| IPO Date: |
March 26, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.58B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.33 | 3.08%
|
| Avg Daily Range (30 D): |
$0.50 | 1.44%
|
| Avg Daily Range (90 D): |
$0.69 | 1.89%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.73M |
| Avg Daily Volume (30 D): |
1.37M |
| Avg Daily Volume (90 D): |
1.63M |
| Trade Size |
| Avg Trade Size (Sh.): |
100 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
67 |
| Institutional Trades |
| Total Institutional Trades: |
2,858 |
| Avg Institutional Trade: |
$2.21M |
| Avg Institutional Trade (30 D): |
$3.16M |
| Avg Institutional Trade (90 D): |
$3.69M |
| Avg Institutional Trade Volume: |
.15M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.27M |
| Avg Closing Trade (30 D): |
$7.51M |
| Avg Closing Trade (90 D): |
$10.14M |
| Avg Closing Volume: |
213.04K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-2.17
|
$-.53
|
$-.61
|
|
Diluted EPS
|
$-2.17
|
$-.53
|
$-.61
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-354.3M
|
$-97.35M
|
$-102.49M
|
|
Operating Income / Loss
|
$-362.04M
|
$-103.61M
|
$-99.49M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$115.62M
|
$-70.8M
|
$186.8M
|
|
PE Ratio
|
|
|
|
|
|
|